LY-2599666 for alzheimer disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Nov 2015: Trial registered, NCT02614131

The trials

NCT02614131: A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

State
Stopped early
Phase
Phase 1
People
50 taking part
Started
Dec 2015
Primary completion
Dec 2016
Arms
LY2599666 (Part A), LY2599666 (Part B)
Results
Posted on the registry
  1. 25 Nov 2015: Trial registered
  2. 23 Sep 2019: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.